Clinical Trials Directory

Trials / Conditions / Lymphocytic Leukemia, Chronic

Lymphocytic Leukemia, Chronic

31 registered clinical trials studyying Lymphocytic Leukemia, Chronic — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingCAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
NCT04704323
Catapult TherapeuticsPhase 1
CompletedA Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With
NCT02500407
Genentech, Inc.Phase 1 / Phase 2
TerminatedDuvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)
NCT02292225
SecuraBioPhase 1
CompletedComparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With
NCT02242942
Hoffmann-La RochePhase 3
CompletedA Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic Leukemia
NCT01685892
Genentech, Inc.Phase 1
CompletedA Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chr
NCT01609023
Hoffmann-La Roche—
CompletedA Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Prev
NCT01414205
Genentech, Inc.Phase 2
CompletedA Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therap
NCT01263704
Hoffmann-La RochePhase 2
TerminatedA Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphoc
NCT01271010
Hoffmann-La RochePhase 4
CompletedA Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Un
NCT01300247
Genentech, Inc.Phase 1
TerminatedA Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Part
NCT01283386
Hoffmann-La RochePhase 4
CompletedA Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Pa
NCT01292603
Hoffmann-La RochePhase 1
CompletedAn Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lympho
NCT01488162
Hoffmann-La Roche—
CompletedAn Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy
NCT01224093
Hoffmann-La Roche—
CompletedA Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe
NCT01056510
Hoffmann-La RochePhase 4
CompletedA Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
NCT01178086
Hoffmann-La Roche—
CompletedCLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chr
NCT02053610
Hoffmann-La RochePhase 3
CompletedCLL11: A Study of Rituximab With Chlorambucil or Chlorambucil Alone in Patients With Previously Untreated Chro
NCT01998880
Hoffmann-La RochePhase 3
CompletedCLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chr
NCT01010061
Hoffmann-La RochePhase 3
CompletedAn Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patient
NCT01072240
Hoffmann-La Roche—
CompletedA Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With
NCT00718549
Hoffmann-La RochePhase 3
CompletedA Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Le
NCT00738374
Hoffmann-La RochePhase 2
CompletedAn Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia
NCT01395615
Hoffmann-La Roche—
CompletedA Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With C
NCT00754650
Hoffmann-La RochePhase 2
CompletedA Study of MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.
NCT00532129
Hoffmann-La RochePhase 2
CompletedA Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia
NCT00431873
Mirati Therapeutics Inc.Phase 2
CompletedA Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
NCT02533401
Hoffmann-La RochePhase 2
CompletedCHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymp
NCT02013817
Hoffmann-La RochePhase 2
CompletedFludarabine, Rituximab, and Alemtuzumab for B-Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT00143065
Ohio State University Comprehensive Cancer CenterPhase 2
CompletedStudy Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malign
NCT00241358
Washington University School of MedicinePhase 1 / Phase 2
CompletedStudy of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
NCT00143845
University of Michigan Rogel Cancer CenterPhase 2